Neuronetics Company
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Technology:
Neuromodulation
Funding Status:
IPO
Number Of Exists:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Investors Number:
15
Employee Number:
101-250
Last Funding Date:
2021
Headquarters:
Malvern, Pennsylvania, United States
Last Funding Type:
Post-IPO Equity
Total Funding:
248400000
Founded Date:
2003
Industry:
Biotechnology, Health Care, Medical Device, Therapeutics
Estimated Revenue:
$10M to $50M